2023 - 2027 Development of a novel therapeutic strategy targeting the microenvironment that tolerates the progression of refractory lung cancer
2023 - 2027 Functional analysis of TLS, tumor-infiltrating B-cell, by spatial multi-omics profiling and its application to tumor immunotherapy
2022 - 2027 耐性化機序に基づいたHER2陽性乳癌に対する治療戦略の開発
2023 - 2026 メタゲノム解析によるCOPD合併肺がんの臓器横断的ディスバイオーシスの解明
2023 - 2026 Elucidation of Tumor Microenvironment Network Regulated by Fibrinolysis Inhibitory Factor and Its Therapeutic Application
2022 - 2026 マトリセルラータンパク質阻害によるがん微小環境の破壊と抗腫瘍効果の検討
2022 - 2026 マトリセルラータンパク質阻害によるがん微小環境の破壊と抗腫瘍効果の検討
2022 - 2025 Clarification of the mechanism for endogenous retrovirus to get involved in the antitumor immunity response
2020 - 2023 Novel therapeutic approaches for lung cancer by using iPS cell-derived organoids
2018 - 2021 Development of innovative therapeutic antibodies targeting the inflammatory tumor microenvironment in refractory thoracic tumors
2018 - 2021 Novel therapeutic strategy focused on EGFR-binding protein LRIG1 for EGFR-mutant lung cancer
2017 - 2020 Mechanistic analysis of an unidentified downstream signals of S100A8/A9 receptors that play a crucial role in acquisition of metastatic force and formation of cancer microenvironment.
2016 - 2019 Development of new therapeutic strategy based on gene expression and mutation profiles in EGFR mutant lung cancer
2016 - 2017 EGFR-TKI resistance and epigenetic alterations in lung cancer treatment
2014 - 2017 Identification of novel targets in the treatment of lung cancer
2013 - 2016 Understanding and overcoming drug resistance to EGFR-inhibitors for lung cancer
Show all
Papers (136):
Kotaro Nomura, Kazuki Takada, Fumihiko Kinoshita, Satoshi Muto, Taichi Matsubara, Yasunobu Kouki, Shinya Katsumata, Akira Hamada, Naoki Haratake, Kosuke Fujino, et al. Prognostic impact of PD-L1 expression in surgically resected EGFR-mutant lung adenocarcinoma: A real-world database study in Japan (CReGYT-01 EGFR study). International journal of cancer. 2024
Haruki Choshi, Kentaroh Miyoshi, Maki Tanioka, Hayato Arai, Shin Tanaka, Kazuhiko Shien, Ken Suzawa, Mikio Okazaki, Seiichiro Sugimoto, Shinichi Toyooka. Long Short-Term Memory Algorithm for Personalized Tacrolimus Dosing: A Simple and Effective Time Series Forecasting Approach Post-Lung Transplantation. The Journal of Heart and Lung Transplantation. 2024
Tomohiro Habu, Hiromasa Yamamoto, Kentaro Nakata, Kohei Hashimoto, Shin Tanaka, Kazuhiko Shien, Ken Suzawa, Kentaroh Miyoshi, Mikio Okazaki, Seiichiro Sugimoto, et al. Prophylactic effect of tissue flap in the prevention of bronchopleural fistula after surgery for lung cancer. Surgery today. 2024
Shinichi Kawana, Seiichiro Sugimoto, Kei Matsubara, Haruki Choshi, Shin Tanaka, Megumi Ishihara, Tomohiro Habu, Kohei Hashimoto, Ken Suzawa, Kazuhiko Shien, et al. Augmented humoral response to third and fourth dose of SARS-CoV-2 mRNA vaccines in lung transplant recipients. Respiratory investigation. 2024. 62. 5. 804-810
Kazuma Iwata, Ken Suzawa, Kohei Hashimoto, Shin Tanaka, Kazuhiko Shien, Kentaroh Miyoshi, Hiromasa Yamamoto, Mikio Okazaki, Seiichiro Sugimoto, Shinichi Toyooka. Utility of neutrophil-to-lymphocyte ratio as an indicator of tumor immune status in non-small cell lung cancer. Japanese journal of clinical oncology. 2024. 54. 8. 895-902
2013/04 - 2014/03 Okayama University Graduate School of Medicine , Dentistry and Pharmaceutical Sciences
2010/04 - 2013/03 Okayama University Graduate School of Medicine , Dentistry and Pharmaceutical Sciences
Show all
Association Membership(s) (6):
JAPAN SOCIETY OF CLINICAL ONCOLOGY
, THE JAPAN LUNG CANCER SOCIETY
, THE JAPANESE ASSOCIATION FOR CHEST SURGERY
, THE JAPANESE ASSOCIATION FOR THORACIC SURGERY
, JAPAN SURGICAL SOCIETY
, 日本癌学会